In RCC, HIF1α reprograms the metabolism of cancer cells, in part by increasing the glucose uptake, and in part by controlling the glucose flux through the glycolytic and pentose phosphate pathways [25, 26]. The gene discussed is HIF1A; the disease is cancer.